Prostate Cancer - Results from #25360

Proton beam radiotherapy in the U.S. Medicare population: growth in use between 2006 and 2009: Data Points # 10 - Abstract July 19, 2012

Low-dose chemotherapy with insulin (insulin potentiation therapy) in combination with hormone therapy for treatment of castration-resistant prostate cancer - Abstract July 19, 2012

Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy - Abstract July 19, 2012

A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomy - Abstract July 18, 2012

Cardiometabolic complications after androgen deprivation therapy in a man with prostate cancer: effects of 3 years intermittent testosterone supplementation - Abstract July 18, 2012

Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients - Abstract July 18, 2012

Managing side effects of the novel taxane cabazitaxel in castrate-resistant prostate cancer - Abstract July 18, 2012

Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy - Abstract July 18, 2012

Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy - Abstract July 18, 2012

MicroRNAs and Prostate Cancer: From Preclinical Research to Translational Oncology - Abstract July 18, 2012

Information on pros and cons of prostate-specific antigen testing to men prior to blood draw: A study from the National Prostate Cancer Register (NPCR) of Sweden - Abstract July 18, 2012

Value of contrast-enhanced sonographic micro flow imaging for prostate cancer detection with t-PSA level of 4-10ng/mL - Abstract July 18, 2012

Cavernosal nerve preservation during robot-assisted radical prostatectomy is a graded rather than an all-or-none phenomenon: objective demonstration by assessment of residual nerve tissue on surgical specimens - Abstract July 17, 2012

Emerging biomarkers of prostate cancer (Review) - Abstract July 17, 2012

Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer - Abstract July 17, 2012

Cancer immunotherapy: a paradigm shift for prostate cancer treatment - Abstract July 17, 2012

Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI - Abstract July 17, 2012

Nanoparticle therapeutics for prostate cancer treatment - Abstract July 17, 2012

Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy - Abstract July 17, 2012

[Chemoprevention of prostate cancer - a plea] - Abstract July 17, 2012

Page 1269 of 1435